US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants
Patent 10632191 was granted and assigned to Infectious Disease Research Institute on April, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 1 Mar, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106321910
Date of Patent
April 28, 2020
0Patent Application Number
157295120
Date Filed
October 10, 2017
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10632191
Date of patent
April 28, 2020
Patent application number
15729512
Date Filed
October 10, 2017
Patent primary examiner
Find more entities like US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
